A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1998
12/23/1998	EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
12/23/1998	EP0885193A1 Triaryl compounds
12/23/1998	EP0885188A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
12/23/1998	EP0884947A1 Dna vaccination for induction of suppressive t cell response
12/23/1998	EP0591528B1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND ANTI-INFLAMMATORY CONTAINING THE SAME
12/23/1998	EP0494914B1 2-spirocyclopropyl cephalosporin derivatives and processes for the preparation thereof
12/23/1998	CN1202907A Cyclopeptide derivatives
12/23/1998	CN1202904A Cyclopeptolides
12/23/1998	CN1202894A Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases
12/23/1998	CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists
12/23/1998	CN1202828A Substituted pyrzolyl benzenesulfonanides for use in veterinary
12/23/1998	CN1202823A Hydrolysis-optimized liplid emulsions and use thereof
12/23/1998	CN1202371A Specific Chinese drug for curing common cold and abatement of fever
12/23/1998	CN1041311C Method for preparing benzopyran and related LTB4 antagonists
12/23/1998	CA2295994A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998	CA2295440A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998	CA2294569A1 Secreted proteins and polynucleotides encoding them
12/23/1998	CA2294563A1 New human lysophospholipase
12/23/1998	CA2294519A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998	CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998	CA2294047A1 Crystalline roxifiban
12/23/1998	CA2293998A1 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998	CA2292883A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
12/23/1998	CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/22/1998	US5852190 Diazepinoindoles as phosphodiesterase IV inhibitors
12/22/1998	US5852173 TNF receptor death ligand proteins and inhibitors of ligand binding
12/22/1998	US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998	US5852055 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
12/22/1998	US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same
12/22/1998	US5852002 Treatment of conditions and disease
12/22/1998	US5851814 Human elastate IV
12/22/1998	US5851793 Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2
12/22/1998	US5851784 Human phosphodiesterase type IVC, and its production and use
12/22/1998	US5851528 Methods of inhibiting complement activation
12/18/1998	CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998	WO1998056925A1 Human protein phosphatase ii-c-like protein
12/17/1998	WO1998056913A1 Smad6 and uses thereof
12/17/1998	WO1998056909A2 Secreted proteins and polynucleotides encoding them
12/17/1998	WO1998056898A2 Human peroxisomal thioesterase
12/17/1998	WO1998056817A1 Composition and methods for the treatment of inflammatory diseases
12/17/1998	WO1998056783A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
12/17/1998	WO1998056771A2 Piperazine derivatives and their use as anti-inflammatory agents
12/17/1998	WO1998056400A1 Anti-inflammatory and other therapeutic, prophylactic or diagnostic uses of synthetic melittin and new related peptides
12/17/1998	WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998	WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998	WO1998039034A3 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
12/17/1998	WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998	CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998	CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998	CA2293363A1 Secreted proteins and polynucleotides encoding them
12/17/1998	CA2293248A1 Human protein phosphatase ii-c-like protein
12/17/1998	CA2292339A1 Smad6 and uses thereof
12/16/1998	EP0884386A1 Sodium channel receptor
12/16/1998	EP0884316A1 Quinazoline-4-one AMPA antagonists
12/16/1998	EP0884308A2 A method of preparing 16-dehydro vitamin D compounds
12/16/1998	EP0883628A1 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof
12/16/1998	EP0883616A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
12/16/1998	EP0883405A1 Amidino protease inhibitors
12/16/1998	EP0883402A1 Novel cycloalkyl substituded imidazoles
12/16/1998	EP0808156B1 Compositions comprising nanoparticles of nsaid
12/16/1998	EP0699191B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/16/1998	EP0610447B1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS
12/16/1998	CN1202170A Quinoline derivatives as type 1V phosphodiesterase inhibitors
12/16/1998	CN1202164A Diarylalkenylamine derivatives
12/16/1998	CN1202163A Benzothiazolone derivatives
12/16/1998	CN1202161A Macrocyclic compounds as metalloprotease inhibitors
12/16/1998	CN1202151A Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
12/16/1998	CN1202111A Use of epinastine in the treatment of pain
12/15/1998	US5849943 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
12/15/1998	US5849918 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
12/15/1998	US5849896 α-subunit of the Mac-1 leukocyte adhesion receptor
12/15/1998	US5849799 Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
12/15/1998	US5849798 Polyaromatic heterocyclic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/15/1998	US5849794 Guanylhydrazones and their use to treat inflammatory conditions
12/15/1998	US5849776 Medicaments based on metronidazole or on a synergic mixture of metronidazole and clindamycin
12/15/1998	US5849770 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
12/15/1998	US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998	US5849709 Saccharopeptides and derivatives thereof
12/15/1998	US5849283 Human interleukin-6 receptor antagonists
12/15/1998	CA2163667C Imidazole lipoxygenase inhibitors
12/15/1998	CA2160462C Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
12/15/1998	CA1340247C Choline salts of arylmethylenyl thiazolidinones and oxazolidinones
12/11/1998	CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998	WO1998055617A1 Translational regulator initiation factor 4e-binding protein
12/10/1998	WO1998055613A1 Zinc ring protein
12/10/1998	WO1998055600A2 New human ribonuclease
12/10/1998	WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998	WO1998055468A1 Oxazole compounds useful as pge2 agonists and antagonists
12/10/1998	WO1998055439A1 Indane compounds and their pharmaceutical use
12/10/1998	WO1998055113A1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol
12/10/1998	WO1998036728A3 Sustained analgesia achieved with buprenorphine
12/10/1998	WO1998035967A3 Biazacyclic crf antagonists
12/10/1998	CA2292892A1 Translational regulator initiation factor 4e-binding protein
12/10/1998	CA2292891A1 Zinc ring protein
12/10/1998	CA2291661A1 New human ribonuclease
12/10/1998	CA2234411A1 Novel compounds
12/09/1998	EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998	EP0882706A1 Cell adhesion inhibitors
12/09/1998	EP0882066A1 Peptide derivatives
12/09/1998	EP0882047A1 Quinolones and their therapeutic use

1 ... 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 ... 1272